Current
Neuro-Oncology


Volume 22 Number 4
April 2020


Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 4, April


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS




GLIOMAS


HIGH-GRADE GLIOMAS


LOW-GRADE GLIOMAS




DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


GLIOBLASTOMA


GLIOSARCOMA


DIFFUSE MIDLINE GLIOMA




OTHER ASTROCYTIC TUMORS


PILOCYTIC ASTROCYTOMA




EMBRYONAL TUMORS


MEDULLOBLASTOMA




MENINGIOMAS


MENINGIOMA




FAMILIAL TUMOR SYNDROMES





CENTRAL NERVOUS SYSTEM TUMORS


Bulubas L, Sardesh N, Traut T, Findlay A, Mizuiri D, Honma SM, Krieg SM, Berger MS, Nagarajan SS, Tarapore PE.
Motor Cortical Network Plasticity in Patients With Recurrent Brain Tumors.
Front Hum Neurosci. 2020 Apr 3. 2020;14:118. Doi10.3389/fnhum.2020.00118. _




Carles C, Esquirol Y, Turuban M, Piel C, Migault L, Pouchieu C, Bouvier G, Fabbro-Peray P, Lebailly P, Baldi I.
Residential proximity to power lines and risk of brain tumor in the general population.
Environ Res. [2020 Apr 4]. 2020;185:109473. Doi 10.1016/j.envres.2020.109473. _




Guidi M, Giunti L, Buccoliero AM, Santi M, Spacca B, De Masi S, Genitori L, Sardi I.
Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors.
Front Pediatr. 2020 Apr 9. 2020;8:135. Doi 10.3389/fped.2020.00135. _




Haldbo-Classen L, Amidi A, Lukacova S, Wu LM, Oettingen GV, Lassen-Ramshad Y, Zachariae R, Kallehauge JF, Høyer M.
Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours.
Radiother Oncol. [2020 Mar 28]. 2020;148:1-7. Doi 10.1016/j.radonc.2020.03.023. _




Moser O, Zimmermann M, Meyer U, Klapper W, Oschlies I, Schrappe M, Attarbaschi A, Mann G, Niggli F, Spix C, Kontny U, Klingebiel T, Reiter A, Burkhardt B, Woessmann W.
Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group.
Haematologica. [2020 Apr 16]. 2020;haematol.2019.244780. Doi 10.3324/haematol.2019.244780. _




Shah AH, Mahavadi AK, Morell A, Eichberg DG, Luther E, Sarkiss CA, Semonche A, Ivan ME, Komotar RJ.
Salvage craniotomy for treatment-refractory symptomatic cerebral radiation necrosis.
Neurooncol Pract. [2019 Jul 3]. 2020;7(1):94-102. Doi 10.1093/nop/npz028. _




Shao J, Radakovich NR, Grabowski M, Borghei-Razavi H, Knusel K, Joshi KC, Muhsen BA, Hwang L, Barnett GH, Mohammadi AM.
Lessons Learned in Using Laser Interstitial Thermal Therapy for Treatment of Brain Tumors: A Case Series of 238 Patients from a Single Institution.
World Neurosurg. [2020 Apr 13]. 2020;S1878-8750(20)30684-7. Doi 10.1016/j.wneu.2020.03.213. _




Wallace D, Taylor DR, Pan H, Hwang S, Lucas JT Jr, Klimo P Jr, Upadhyaya SA, Boop FA.
Treatment-related calvarial lesions in pediatric brain tumor survivors.
Pediatr Blood Cancer. [2020 Apr 14]. 2020;67(6):e28189. Doi 10.1002/pbc.28189. _



GLIOMAS


Chai RC, Zhang YW, Liu YQ, Chang YZ, Pang B, Jiang T, Jia WQ, Wang YZ.
The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Acta Neuropathol Commun. 2020 Mar 30. 2020;8(1):40. Doi 10.1186/s40478-020-00913-w. _




Mantilla EC Jr, Abramowitz J, Dan TU, Pan E.
Prolonged Steroid Dependence in Adult Patients With Glioma.
Anticancer Res. 2020 Apr. 2020;40(4):2059‐2064. Doi 10.21873/anticanres.14163. _




Maynard J, Okuchi S, Wastling S, Busaidi AA, Almossawi O, Mbatha W, Brandner S, Jaunmuktane Z, Koc AM, Mancini L, Jäger R, Thust S.
World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
Radiology. [2020 Apr 21]. 2020;191832. Doi 10.1148/radiol.2020191832. _




Ruff M, Kizilbash S, Buckner J.
Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development.
Expert Rev Anticancer Ther. [2020 Apr 17]. 2020;10.1080/14737140.2020.1757440. Doi 10.1080/14737140.2020.1757440. _



HIGH-GRADE GLIOMAS



Cluceru J, Nelson SJ, Wen Q, Phillips JJ, Shai A, Molinaro AM, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Chunduru P, Villanueva-Meyer JE, Cha S, Chang SM, Berger MS, Lupo JM.
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas.
Neuro Oncol. [2020 Apr 22]. 2020;noaa094. Doi 10.1093/neuonc/noaa094. _




Eichberg DG, Di L, Morell AA, Shah AH, Semonche AM, Chin CN, Bhatia RG, Jamshidi AM, Luther EM, Komotar RJ, Ivan ME.
Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis.
J Neurooncol. [2020 Mar 27]. 2020;10.1007/s11060-020-03474-z. Doi 10.1007/s11060-020-03474-z. _




Feraco P, Bacci A, Ferrazza P, van den Hauwe L, Pertile R, Girlando S, Barbareschi M, Gagliardo C, Morganti AG, Petralia B.
Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas.
Diagnostics (Basel). 2020 Apr 23. 2020;10(4):E247. Doi 10.3390/diagnostics10040247. _




Hong JB, Roh TH, Kang SG, Kim SH, Moon JH, Kim EH, Ahn SS, Choi HJ, Cho J, Suh CO, Chang JH.
Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas.
Cancer Res Treat. [2020 Apr 23]. 2020;10.4143/crt.2020.057. Doi 10.4143/crt.2020.057. _




Komakech A, Im JH, Gwak HS, Lee KY, Kim JH, Yoo BC, Cheong H, Park JB, Kwon JW, Shin SH, Yoo H.
Dexamethasone Interferes with Autophagy and Affects Cell Survival in Irradiated Malignant Glioma Cells.
J Korean Neurosurg Soc. [2020 Apr 10]. 2020;10.3340/jkns.2019.0187. Doi 10.3340/jkns.2019.0187. _.




Zigiotto L, Annicchiarico L, Corsini F, Vitali L, Falchi R, Dalpiaz C, Rozzanigo U, Barbareschi M, Avesani P, Papagno C, Duffau H, Chioffi F, Sarubbo S.
Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery.
J Neurooncol. [2020 Apr 17]. 2020;10.1007/s11060-020-03494-9. Doi 10.1007/s11060-020-03494-9. _



LOW-GRADE GLIOMAS



Darvishi P, Batchala PP, Patrie JT, Poisson LM, Lopes MB, Jain R, Fadul CE, Schiff D, Patel SH.
Prognostic Value of Preoperative MRI Metrics for Diffuse Lower-Grade Glioma Molecular Subtypes.
AJNR Am J Neuroradiol. [2020 Apr 23]. 2020;10.3174/ajnr.A6511. Doi 10.3174/ajnr.A6511. _




Fangusaro J, Bandopadhayay P.
The "Risk" in Pediatric Low-Grade Glioma.
Cancer Cell. Pub 2020 Apr 13. 2020;37(4):424‐425. Doi 10.1016/j.ccell.2020.03.020. _
Referring to: Ryall S, et al.,Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas. Cancer Cell. 2020 Apr 13. 2020;37(4):569‐583.e5. Doi 10.1016/j.ccell.2020.03.011. _




Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D'Souza D, Laack NN, Barani IJ, Kwok Y, Wahl DR, Strasser JF, Won M, Mehta MP.
Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424.
Int J Radiat Oncol Biol Phys. [2020 Apr 3]. 2020;S0360-3016(20)30957-3. Doi 10.1016/j.ijrobp.2020.03.027. _




Ryall S, Zapotocky M, Fukuoka K, Nobre L, Guerreiro Stucklin A, Bennett J, Siddaway R, Li C, Pajovic S, Arnoldo A, Kowalski PE, Johnson M, Sheth J, Lassaletta A, Tatevossian RG, Orisme W, Qaddoumi I, Surrey LF, Li MM, Waanders AJ, Gilheeney S, Rosenblum M, Bale T, Tsang DS, Laperriere N, Kulkarni A, Ibrahim GM, Drake J, Dirks P, Taylor MD, Rutka JT, Laughlin S, Shroff M, Shago M, Hazrati LN, D'Arcy C, Ramaswamy V, Bartels U, Huang A, Bouffet E, Karajannis MA, Santi M, Ellison DW, Tabori U, Hawkins C.
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.
Cancer Cell. 2020 Apr 13. 2020;37(4):569‐583.e5. Doi 10.1016/j.ccell.2020.03.011. _



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA



Ahmadipour Y, Gembruch O, Pierscianek D, Sure U, Jabbarli R.
Does the expression of glial fibrillary acid protein (GFAP) stain in glioblastoma tissue have a prognostic impact on survival?
Neurochirurgie. [2020 Apr 9]. 2020;S0028-3770(20)30038-2. Doi 10.1016/j.neuchi.2019.12.012. _




Balana C, Vaz MA, Sepúlveda JM, Mesia C, Del Barco S, Pineda E, Muñoz-Langa J, Estival A, de Las Peñas R, Fuster J, Gironés R, Navarro LM, Gil-Gil M, Alonso M, Herrero A, Peralta S, Olier C, Perez-Segura P, Covela M, Martinez-García M, Berrocal A, Gallego O, Luque R, Perez-Martín FJ, Esteve A, Munne N, Domenech M, Villa S, Sanz C, Carrato C.
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond six cycles in patients with glioblastoma (GEINO 14-01).
Neuro Oncol. [2020 Apr 24]. 2020;noaa107. Doi 10.1093/neuonc/noaa107. _




Bette S, Barz M, Ly Nham H, Huber T, Berndt M, Sales A, Schmidt-Graf F, Meyer HS, Ryang YM, Meyer B, Zimmer C, Kirschke JS, Wiestler B, Gempt J.
Image Analysis Reveals Microstructural and Volumetric Differences in Glioblastoma Patients with and without Preoperative Seizures.
Cancers (Basel). 2020 Apr 17. 2020;12(4):E994. Doi 10.3390/cancers12040994. _




Guberina N, Pöttgen C, Kebir S, Lazaridis L, Scharmberg C, Lübcke W, Niessen M, Guberina M, Scheffler B, Jendrossek V, Jabbarli R, Pierscianek D, Sure U, Schmidt T, Oster C, Hau P, Grosu AL, Stuschke M, Glas M, Nour Y, Lüdemann L.
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
Radiat Oncol. 2020 Apr 19. 2020;15(1):83. Doi 10.1186/s13014-020-01521-7. _




Kaley TJ, Panageas KS, Pentsova EI, Mellinghoff IK, Nolan C, Gavrilovic I, DeAngelis LM, Abrey LE, Holland EC, Omuro A, Lacouture ME, Ludwig E, Lassman AB.
Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma.
Ann Clin Transl Neurol. [2020 Apr 15]. 2020;7(4):429-436. Doi 10.1002/acn3.51009. _




Kumar N, Kumar R, Sharma SC, Mukherjee A, Khandelwal N, Tripathi M, Miriyala R, Oinam AS, Madan R, Yadav BS, Khosla D, Kapoor R.
Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols.
Neurooncol Pract. [2019 Jul 18]. 2020;7(1):86-93. Doi 10.1093/nop/npz024. _




Loong HH, Wong AM, Chan DT, Cheung MS, Chow C, Ding X, Chan AK, Johnston PA, Lau JY, Poon WS, Wong N.
Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?
J Clin Neurosci. [2020 Apr 24]. 2020;S0967-5868(20)30604-4. Doi 10.1016/j.jocn.2020.04.107. _




Maas SLN, Abels ER, Van De Haar LL, Zhang X, Morsett L, Sil S, Guedes J, Sen P, Prabhakar S, Hickman SE, Lai CP, Ting DT, Breakefield XO, Broekman MLD, El Khoury J.
Glioblastoma hijacks microglial gene expression to support tumor growth.
J Neuroinflammation. 2020 Apr 16. 2020;17(1):120. Doi 10.1186/s12974-020-01797-2. _




Papale M, Buccarelli M, Mollinari C, Russo MA, Pallini R, Ricci-Vitiani L, Tafani M.
Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression.
Int J Mol Sci. 2020 Apr 11. 2020;21(8):E2660. Doi 10.3390/ijms21082660. _




Press RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, Morgan TM, Behera M, Sengupta S, Voloschin AD, Olson JJ, Hasan S, Blumenthal DT, Curran WJ, Eaton BR, Shu HG, Zhong J.
Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Cancer. [2020 Apr 28]. 2020;10.1002/cncr.32797. Doi 10.1002/cncr.32797. _




Regueira PSS, Cerejeira JMS.
Delirium as the primary manifestation of glioblastoma multiforme: a report of two cases.
Psychogeriatrics. [2020 Apr 16]. 2020;10.1111/psyg.12555. Doi 10.1111/psyg.12555. _




Sarkar S, Yang R, Mirzaei R, Rawji K, Poon C, Mishra MK, Zemp FJ, Bose P, Kelly J, Dunn JF, Yong VW.
Control of brain tumor growth by reactivating myeloid cells with niacin.
Sci Transl Med. 2020 Apr 1. 2020;12(537):eaay9924. Doi 10.1126/scitranslmed.aay9924. _




Schröter N, Lützen N, Doostkam S, Berger B.
Glioblastoma evolving within 10 days following unremarkable computer tomography of the brain: a case report.
Int J Neurosci. [2020 Apr 15]. 2020;1‐4. Doi 10.1080/00207454.2020.1753730. _




Shimizu T, Matsushima S, Fukasawa N, Akasaki Y, Mori R, Ojiri H.
Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.
J Clin Neurosci. [2020 Apr 11]. 2020;S0967-5868(20)30267-8. Doi 10.1016/j.jocn.2020.04.016. _




Tabrizi S, Trippa L, Cagney D, Tanguturi S, Ventz S, Fell G, Wen PY, Alexander BM, Rahman R.
A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Pub Randomized Trials of Glioblastoma in the Elderly.
Neuro Oncol. [2020 Apr 27]. 2020;noaa111. Doi 10.1093/neuonc/noaa111. _




Troya-Castilla M, Kaen A, Márquez-Rivas FJ, Cossio PI, Díaz FR, Narros Gimenez JL, Gonzalez-Pombo M, Cancela P, Fernández-Nogueras MS, Arráez MÁ.
Impact of early re-operation on the prognosis of patients operated on for glioblastoma.
World Neurosurg. [2020 Apr 21]. 2020;S1878-8750(20)30779-8. Doi 10.1016/j.wneu.2020.04.072. _




Valiyaveettil D, Malik M, Akram KS, Ahmed SF, Joseph DM.
Prospective study to assess the survival outcomes of planned irradiation of ipsilateral subventricular and periventricular zones in glioblastoma.
Ecancermedicalscience. 2020 Mar 26. 2020;14:1021. Doi: 10.3332/ecancer.2020.1021. _




Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger AB.
Glioblastoma-mediated immune dysfunction limits CMV-specific T cells and therapeutic responses; results from a Phase I/II trial.
Clin Cancer Res. [2020 Apr 16]. 2020;clincanres.0176.2020. Doi 10.1158/1078-0432.CCR-20-0176. _




Yaprak G, Isık N, Gemici C, Pekyurek M, Ceylaner Bıcakcı B, Demircioglu F, Tatarlı N.
Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
Stereotact Funct Neurosurg. [2020 Apr 3]. 2020;1‐9. Doi 10.1159/000505706. _



GLIOSARCOMA



Jiang N, Larrazabal R, Alsunbul W, Lu JQ.
Angiosarcomatous component in gliosarcoma: case report and consideration of diagnostic challenge and hemorrhagic propensity.
J Biomed Res. [2019 Dec 20]. 2020;34(2):143–148. Doi 10.7555/JBR.33.20190080. _



DIFFUSE MIDLINE GLIOMA



Bellat V, Alcaina Y, Tung CH, Ting R, Michel A, Souweidane M, Law B.
A Combined Approach of Convection-Enhanced Delivery of Peptide Nanofiber Reservoir to Prolong Delivery of DM1 for Diffuse Intrinsic Pontine Glioma Treatment.
Neuro Oncol. [2020 Apr 17]. 2020;noaa101. Doi 10.1093/neuonc/noaa101. _




Chen J, Lin Z, Barrett L, Dai L, Qin Z.
Identification of new therapeutic targets and natural compounds against diffuse intrinsic pontine glioma (DIPG).
Bioorg Chem. [2020 Apr 13]. 2020;99:103847. Doi 10.1016/j.bioorg.2020.103847. _




Chiang J, Diaz AK, Makepeace L, Li X, Han Y, Li Y, Klimo P Jr, Boop FA, Baker SJ, Gajjar A, Merchant TE, Ellison DW, Broniscer A, Patay Z, Tinkle CL.
Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.
Acta Neuropathol Commun. 2020 Apr 23. 2020;8(1):57. Doi 10.1186/s40478-020-00930-9. _




Liu Z, Feng S, Li J, Cao H, Huang J, Fan F, Cheng L, Liu Z, Cheng Q.
The Epidemiological Characteristics and Prognostic Factors of Low-Grade Brainstem Glioma: A Real-World Study of Pediatric and Adult Patients.
Front Oncol. 2020 Apr 9. 2020;10:391. Doi 10.3389/fonc.2020.00391. _




Su JM, Murray JC, McNall-Knapp RY, Bowers DC, Shah S, Adesina AM, Paulino AC, Jo E, Mo Q, Baxter PA, Blaney SM.
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
Pediatr Blood Cancer. [2020 Apr 14]. 2020;67(6):e28283. Doi 10.1002/pbc.28283. _



OTHER ASTROCYTIC TUMORS



PILOCYTIC ASTROCYTOMA



Mair MJ, Wöhrer A, Furtner J, Simonovska A, Kiesel B, Oberndorfer S, Ungersböck K, Marosi C, Sahm F, Hainfellner JA, Rössler K, Preusser M, Widhalm G, Berghoff AS.
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.
J Neurooncol. [2020 Apr 27]. 2020;10.1007/s11060-020-03513-9. Doi 10.1007/s11060-020-03513-9. _



EMBRYONAL TUMORS



MEDULLOBLASTOMA



Alharbi M, Mobark N, Bashawri Y, Abu Safieh L, Alowayn A, Aljelaify R, AlSaeed M, Almutairi A, Alqubaishi F, AlSolme E, Ahmad M, Al-Banyan A, Alotabi FE, Serrano J, Snuderl M, Al-Rashed M, Abedalthagafi M.
Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions.
Front Neurol. 2020 Mar 20. 2020;11:167. Doi 10.3389/fneur.2020.00167. _




Das D, Mahanta LB, Ahmed S, Baishya BK.
Classification of childhood medulloblastoma into WHO-defined multiple subtypes based on textural analysis.
J Microsc. [2020 Apr 9]. 2020;10.1111/jmi.12893. Doi 10.1111/jmi.12893. _.




Dhall G, O'Neil SH, Ji L, Haley K, Whitaker AM, Nelson MD, Gilles F, Gardner SL, Allen JC, Cornelius AS, Pradhan K, Garvin JH, Olshefski RS, Hukin J, Comito M, Goldman S, Atlas MP, Walter AW, Sands S, Sposto R, Finlay JL.
Excellent Outcome of Young Children with Nodular Desmoplastic Medulloblastoma Treated on "Head Start" III: A Multi-Institutional, Prospective Clinical Trial.
Neuro Oncol. [2020 Apr 18]. 2020;noaa102. Doi 10.1093/neuonc/noaa102. _




Donovan LK, Delaidelli A, Joseph SK, Bielamowicz K, Fousek K, Holgado BL, Manno A, Srikanthan D, Gad AZ, Van Ommeren R, Przelicki D, Richman C, Ramaswamy V, Daniels C, Pallota JG, Douglas T, Joynt ACM, Haapasalo J, Nor C, VlaDoi:u MC, Kuzan-Fischer CM, Garzia L, Mack SC, Varadharajan S, Baker ML, Hendrikse L, Ly M, Kharas K, Balin P, Wu X, Qin L, Huang N, Stucklin AG, Morrissy AS, Cavalli FMG, Luu B, Suarez R, De Antonellis P, Michealraj A, Rastan A, Hegde M, Komosa M, Sirbu O, Kumar SA, Abdullaev Z, Faria CC, Yip S, Hukin J, Tabori U, Hawkins C, Aldape K, Daugaard M, Maris JM, Sorensen PH, Ahmed N, Taylor MD.
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.
Nat Med. [2020 Apr 27]. 26,720–731(2020). Doi 10.1038/s41591-020-0827-2. _




Haque W, Verma V, Brian Butler E, Teh BS.
Prognostic role of chemotherapy, radiotherapy dose, and extent of surgical resection in adult medulloblastoma.
J Clin Neurosci. [2020 Apr 11]. 2020;S0967-5868(20)30140-5. Doi 10.1016/j.jocn.2020.04.002. _




Mynarek M, von Hoff K, Pietsch T, Ottensmeier H, Warmuth-Metz M, Bison B, Pfister S, Korshunov A, Sharma T, Jaeger N, Ryzhova M, Zheludkova O, Golanov A, Rushing EJ, Hasselblatt M, Koch A, Schüller U, von Deimling A, Sahm F, Sill M, Riemenschneider MJ, Dohmen H, Monoranu CM, Sommer C, Staszewski O, Mawrin C, Schittenhelm J, Brück W, Filipski K, Hartmann C, Meinhardt M, Pietschmann K, Haberler C, Slavc I, Gerber NU, Grotzer M, Benesch M, Schlegel PG, Deinlein F, von Bueren AO, Friedrich C, Juhnke BO, Obrecht D, Fleischhack G, Kwiecien R, Faldum A, Kortmann RD, Kool M, Rutkowski S.
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
J Clin Oncol. [2020 Apr 24]. 2020;JCO1903057. Doi 10.1200/JCO.19.03057. _




Shamov TP, Tivcheva I, Eftimov T.
Postoperative Cerebellar Mutism Syndrome in an Adult Patient.
Folia Med (Plovdiv). 2019 Dec 31. 2019;61(4):630‐633. Doi 10.3897/folmed.61.e47829. _



MENINGIOMAS



MENINGIOMA



Assi HI, Hilal L, Abu-Gheida I, Berro J, Sukhon F, Skaf G, Geara F, Boulos F, Charafeddine M, Tabbarah A, Khoury J, Najjar M.
Demographics and outcomes of meningioma patients treated at a tertiary care center in the Middle East.
Clin Neurol Neurosurg. [2020 Apr 20]. 2020;195:105846. Doi 10.1016/j.clineuro.2020.105846. _




Maiuri F, Mariniello G, Peca C, Guadagno E, Corvino S, d'Avanzo S, Del Basso De Caro M, de Divitiis O.
Multicentric and diffuse recurrences of meningiomas.
Br J Neurosurg. [2020 Apr 21]. 2020;1‐8. Doi 10.1080/02688697.2020.1754335. _




Nada A, Abdelrahman A, Cunningham C, Cousins J.
Radio-pathological review of a metastatic renal cell carcinoma within a meningioma: A case report of collision tumor.
Radiol Case Rep. 2020 Mar 28. 2020;15(5):637‐640. Doi 10.1016/j.radcr.2020.02.031. _



FAMILIAL TUMOR SYNDROMES


de Oliveira Nascimento J, Haro LCA, Sá RDS, Storch RE.
Metachronic Breast and Cerebellar Neoplasm in a Young Patient.
Rev Bras Ginecol Obstet. [2020 Mar 30]. 2020;42(2):114-119. Doi 10.1055/s-0040-1701456. _




Kinori M, Armarnik S, Listernick R, Charrow J, Zeid JL.
Neurofibromatosis type 1 associated optic pathway glioma in children - a follow up of 10 years or more.
Am J Ophthalmol. [2020 Apr 10]. 2020;S0002-9394(20)30165-3. Doi 10.1016/j.ajo.2020.03.053. _




Ullrich NJ, Prabhu SP, Reddy AT, Fisher MJ, Packer R, Goldman S, Robison NJ, Gutmann DH, Viskochil DH, Allen JC, Korf B, Cantor A, Cutter G, Thomas C, Perentesis JP, Mizuno T, Vinks AA, Manley PE, Chi SN, Kieran MW; NF Clinical Trials Consortium.
A Phase II Study of Continuous Oral mTOR Inhibitor Everolimus for Recurrent, Radiographic-Progressive Neurofibromatosis Type 1-Associated Pediatric Low-Grade Glioma: A Neurofibromatosis Clinical Trials Consortium Study.
Neuro Oncol. [2020 Apr 1]. 2020;noaa071. Doi 10.1093/neuonc/noaa071. _



bottom